Fundraising Fox
Recludix
San Diego, US · 54 employees on LinkedIn · 3 known investors
Find your way into Recludix
Sign up to see every warm intro you have to Recludix
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Recludix team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Recludix Pharma operates a drug discovery platform that combines custom DNA-encoded libraries (DELs), massively parallel structure-activity relationship analysis, structure-based design, and a family-wide SH2 domain screening panel. It applies this approach first to discover selective SH2 domain inhibitors for treating inflammatory diseases.
Founders & leadership
Investors · 3
In the news
Frequently asked questions
- What does Recludix do?
- Recludix Pharma operates a drug discovery platform that combines custom DNA-encoded libraries (DELs), massively parallel structure-activity relationship analysis, structure-based design, and a family-wide SH2 domain screening panel. It applies this approach first to discover selective SH2 domain inhibitors for treating inflammatory diseases.
- Who are Recludix's investors?
- Recludix's investors include Access Biotechnology, New Enterprise Associates (NEA), Westlake Village BioPartners.
- Where is Recludix headquartered?
- Recludix is headquartered in San Diego, US.